Evidence map›Paper›PMID 31979087›Full record

ArticleToxins2020

Modeling of Effective Antimicrobials to Reduce

Sanjay K Shukla, Tonia C Carter, Zhan Ye, Madhulatha Pantrangi, Warren E Rose

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. DynamicAntibiotics (Basel, Switzerland) · 2024
    Review
  4. Article
  5. iScience · 2022
    Article
  6. Toxins · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sanjay K ShuklaCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA.
Tonia C CarterCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA.
Zhan YeCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA.
Madhulatha PantrangiCenter for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA.
Warren E RosePharmacy Practice Division, School of Pharmacy, University of Wisconsin, Madison, WI 53705, USA.
Marshfield Clinic · USUniversity of Wisconsin–Madison · US

Funding

Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatmentR01AI132627 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ROSE, WARREN E · 2017 to 2021
$2.1M
NIAID NIH HHS R01 AI132627
6 · The paper itself

Abstract

Toxins produced by community-associated methicillin-resistant

Indexed as

Models, BiologicalAnti-Bacterial AgentsBacterial ProteinsClindamycinCommunity-Acquired InfectionsGene Expression Regulation, BacterialLinezolidMethicillin-Resistant Staphylococcus aureusMinocyclineStaphylococcal InfectionsStaphylococcus aureusTrimethoprim, Sulfamethoxazole Drug CombinationVancomycinVirulenceVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsClindamycinLinezolidMinocyclineTrimethoprim, Sulfamethoxazole Drug CombinationVancomycinVirulence Factorsantimicrobialshollow fiber modelmathematical modelingStaphylococcus aureusvirulence

Identifiers

PMID31979087
PMCPMC7076779
OpenAlexW3003276855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.